Seven Fleet Capital Management LP

CIK 0002092021 · Q1 2026

13F Equity AUM

$318.3M

+115.4% QoQ

Positions

115

+30 QoQ

AUM Rank

#5,694

Top 46%

Skill Alpha (FF)

—

No alpha data

Quarters Tracked

~0 years

Portfolio Concentration

Top 5: 41.0%Top 10: 51.3%Top 20: 66.3%

CG ONCOLOGY INC30.6%

TNGX3.3%

RVMD2.5%

TYRA2.4%

LQDA2.2%

AGIO2.2%

IPSC2.1%

ELVN2.0%

PCVX2.0%

TANGO THERAPEUTICS INC2.0%

Others (105)48.7%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare55.9%

Unclassified44.1%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 115Median: 0.31%Avg: 0.87%

0–0.5%

70(13.6%)

0.5–1%

20(14.6%)

1–3%

23(37.9%)

3–5%

1(3.3%)

5%+

1(30.6%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 95Unique: 20vs 20 funds

1.3%Low

115

Fund positions

7,299

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Most Similar Funds

Top 9 benchmark funds with highest portfolio overlap (Jaccard similarity)

GEODE CAPITAL MANAGEMENT, LLC

2.6%

VANGUARD CAPITAL MANAGEMENT LLC

2.5%

MORGAN STANLEY

1.6%

BlackRock, Inc.

STATE STREET CORP

2.1%

BANK OF AMERICA CORP /DE/

1.4%

VANGUARD PORTFOLIO MANAGEMENT LLC

2.3%

FMR LLC

2.1%

JPMORGAN CHASE & CO

1.2%

Jaccard similarity per fund: shared CUSIPs / (fund A + fund B − shared). Higher values indicate more similar portfolios.

Loading overlap analysis...

Position Changes This Quarter

New59Increased36Decreased17Exited29

New Positions

CG ONCOLOGY INC30.6%

+1.4M

IPSC2.1%

+2.9M

TANGO THERAPEUTICS I…2.0%

+301K

AVALO THERAPEUTICS I…1.7%

+360K

MINERVA NEUROSCIENCE…1.7%

+889K

PHARVARIS N V1.3%

+144K

ENLIVEN THERAPEUTICS…1.2%

+95K

ERAS1.1%

+222K

ROIV1.1%

+128K

CYTOMX THERAPEUTICS …1.1%

+714K

Increased

TSHA0.9%

+458K(+274%)

CTMX0.6%

+323K(+660%)

TNGX3.3%

+287K(+133%)

YB4P0.5%

+233K(+371%)

RLAY0.8%

+185K(+253%)

AGIO2.2%

+178K(+560%)

AVTX1.0%

+150K(+238%)

CMPS0.3%

+118K(+295%)

PHVS1.5%

+117K(+212%)

TYRA2.4%

+116K(+146%)

Decreased

CGON1.6%

-1,439,393(-95%)

GON0.2%

-353,700(-45%)

IKT0.2%

-208,048(-39%)

PALI0.1%

-114,400(-35%)

COGT1.8%

-64,700(-30%)

CMPX0.9%

-51,775(-9%)

XNCR0.3%

-29,554(-27%)

ASMB0.5%

-17,615(-24%)

SLNO1.2%

-14,309(-11%)

NKTR0.1%

-10,700(-71%)

Exited

-130,413

-68,569

-9,161

-70,180

-82,500

-166,500

-2,700

-154,109

-3,026

-18,200

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...